Literature DB >> 11948190

Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1.

Valérie Schreiber1, Jean-Christophe Amé, Pascal Dollé, Inès Schultz, Bruno Rinaldi, Valérie Fraulob, Josiane Ménissier-de Murcia, Gilbert de Murcia.   

Abstract

The DNA damage dependence of poly(ADP-ribose) polymerase-2 (PARP-2) activity is suggestive of its implication in genome surveillance and protection. Here we show that the PARP-2 gene, mainly expressed in actively dividing tissues follows, but to a smaller extent, that of PARP-1 during mouse development. We found that PARP-2 and PARP-1 homo- and heterodimerize; the interacting interfaces, sites of reciprocal modification, have been mapped. PARP-2 was also found to interact with three other proteins involved in the base excision repair pathway: x-ray cross complementing factor 1 (XRCC1), DNA polymerase beta, and DNA ligase III, already known as partners of PARP-1. XRCC1 negatively regulates PARP-2 activity, as it does for PARP-1, while being a polymer acceptor for both PARP-1 and PARP-2. To gain insight into the physiological role of PARP-2 in response to genotoxic stress, we developed by gene disruption mice deficient in PARP-2. Following treatment by the alkylating agent N-nitroso-N-methylurea (MNU), PARP-2-deficient cells displayed an important delay in DNA strand breaks resealing, similar to that observed in PARP-1 deficient cells, thus confirming that PARP-2 is also an active player in base excision repair despite its low capacity to synthesize ADP-ribose polymers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948190     DOI: 10.1074/jbc.M202390200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  254 in total

1.  Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress.

Authors:  Martina Bauer; Michael Goldstein; Markus Christmann; Huong Becker; Daniel Heylmann; Bernd Kaina
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy.

Authors:  M Javle; N J Curtin
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

Review 3.  Targeting DNA polymerase ß for therapeutic intervention.

Authors:  Eva M Goellner; David Svilar; Karen H Almeida; Robert W Sobol
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

Review 4.  Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment.

Authors:  Sook Ryun Park; Alice Chen
Journal:  Hematol Oncol Clin North Am       Date:  2012-06       Impact factor: 3.722

5.  The ups and downs of DNA repair biomarkers for PARP inhibitor therapies.

Authors:  Xiaozhe Wang; David T Weaver
Journal:  Am J Cancer Res       Date:  2010-01-03       Impact factor: 6.166

6.  The effect of acute dose charge particle radiation on expression of DNA repair genes in mice.

Authors:  Muhammad Akram Tariq; Ayodotun Soedipe; Govindarajan Ramesh; Honglu Wu; Ye Zhang; Shishir Shishodia; Daila S Gridley; Nader Pourmand; Olufisayo Jejelowo
Journal:  Mol Cell Biochem       Date:  2010-11-16       Impact factor: 3.396

7.  Poly(ADP-ribose) contributes to an association between poly(ADP-ribose) polymerase-1 and xeroderma pigmentosum complementation group A in nucleotide excision repair.

Authors:  Brenee S King; Karen L Cooper; Ke Jian Liu; Laurie G Hudson
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

8.  Involvement of ATM/ATR-p38 MAPK cascade in MNNG induced G1-S arrest.

Authors:  Ke-Qing Zhu; Suo-Jiang Zhang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 9.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

10.  Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry.

Authors:  Richard Wiegand; Jianmei Wu; Xianyi Sha; Patricia LoRusso; Jing Li
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-11-27       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.